Support Line: 0300 373 8500
This is an early phase trial studying the safety and efficacy of a drug called NUC-7738 in people with lymphoma and other types of cancer.
Researchers are looking at what doses of the drug are tolerated, both by itself and in combination with another drug called Pembrolizumab.
NUC-7738 is a new drug and not much is known about it, so it might not benefit all participants. However, the results of the study will go on to help future studies.
• WM that has come back or not responded to treatment
• No further treatment options available